Associate Director, Marketing at Alnylam Pharmaceuticals | USA | $162K/yr – $219K/yr

Alnylam Pharmaceuticals

Associate Director, Marketing

USA (Hybrid)

$162K/yr – $219K/yrSenior Level8+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive national HCP education and peer-to-peer strategy for AMVUTTRA with cross-functional leadership and regulatory alignment.

Own national HCP education and peer-to-peer engagement strategy for the TTR franchise.
Must-have: 8+ years in pharma marketing or medical education with HCP/peer-to-peer focus.
Standout: Cross-functional leadership spanning Medical, Legal, Compliance, Marketing, and field teams.

Job Description

Responsibilities

Peer-to-Peer Education & Speaker Bureau: Lead end-to-end strategy and execution of speaker bureau programs, including speaker identification and selection, training, content development, and ongoing performance optimization.
Educational Content Development: Oversee creation, approval, and lifecycle management of speaker decks, educational toolkits, and HCP-facing materials to ensure scientific accuracy, consistency, and alignment with brand strategy.
Congresses & Educational Presence: Define and execute congress education strategy, including symposia, product theaters, booth content, and congress sponsorships; ensure compliant development and seamless onsite execution.
Media & Digital Education: Drive strategy and execution of HCP-focused media initiatives, including digital education platforms and video content to expand reach and engagement.
HCP Video Content (Recorded HCP Education): Lead development of recorded HCP video content, including identification of speakers, content planning, recording, and deployment for broader educational reach.
Field Team Content & Engagement: Develop and execute KOL-led education and training sessions for field teams to support internal clinical expertise and reinforce key messaging.
Cross-Functional Collaboration: Partner with Medical, Legal, Compliance, Marketing, and field teams to ensure all educational initiatives meet regulatory standards and strategic objectives.
Performance Tracking & Optimization: Establish metrics to evaluate effectiveness of educational programs; continuously refine strategy based on insights and performance data.
Vendor & Agency Management: Oversee external partners supporting content development, logistics, and execution across educational initiatives.
Therapeutic Area Expertise: Maintain deep understanding of disease area, HCP learning needs, and evolving industry best practices to inform education strategy.

Requirements

Bachelor’s degree required; MBA or advanced degree in life sciences or marketing strongly preferred.
8+ years of experience in pharmaceutical or biotech marketing, healthcare consulting, or healthcare agency with a focus on HCP engagement, medical education, or peer-to-peer strategy preferred.
Ability to navigate a dynamic, fast-paced environment by managing competing and complex priorities and engaging with cross-functional partners to ensure goals are met efficiently and collaboratively.
Demonstrate a meticulous attention to detail, ensuring accuracy, consistency, and quality across all deliverables, communications, and project components.
Deep understanding of compliance requirements and experience in highly regulated environments.

Preferred

MBA or advanced degree strongly preferred in life sciences or marketing

Benefits

comprehensive benefits including medical, dental, and vision coverage
life and disability insurance
lifestyle reimbursement program
flexible spending and health savings accounts
401(k) with a generous company match
paid time off, wellness days, holidays, and two company-wide recharge breaks
generous family resources and leave

Alnylam Pharmaceuticals

3.5 Glassdoor

SILENCE DISEASE. AMPLIFY LIFE.TMAlnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.See our social media community guidelines: https://bit.ly/2FcRhJy.Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861Fraudulent Recruitment ActivityBe aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Founded in 2002

Cambridge, Massachusetts, USA

2.7K employees (134 in marketing)

www.alnylam.com

62% recommend to a friend

83% CEO approval